JPH05284937A - Digestive enzyme activity-inhibiting substance extracted from sea alga and dietary food containing the same - Google Patents
Digestive enzyme activity-inhibiting substance extracted from sea alga and dietary food containing the sameInfo
- Publication number
- JPH05284937A JPH05284937A JP4116707A JP11670792A JPH05284937A JP H05284937 A JPH05284937 A JP H05284937A JP 4116707 A JP4116707 A JP 4116707A JP 11670792 A JP11670792 A JP 11670792A JP H05284937 A JPH05284937 A JP H05284937A
- Authority
- JP
- Japan
- Prior art keywords
- amylase
- lipase
- activity
- digestive enzyme
- alga
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Seaweed (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、海藻から抽出した消化
酵素(α−アミラーゼ、リパーゼ等)活性阻害物質及び
該消化酵素活性阻害物質を含有するダイエット食品に関
する。TECHNICAL FIELD The present invention relates to a digestive enzyme (α-amylase, lipase etc.) activity inhibitory substance extracted from seaweed and a diet food containing the digestive enzyme activity inhibitory substance.
【0002】[0002]
【従来の技術と発明が解決しようとする課題】α−アミ
ラーゼはでんぷん、グリコーゲンなどのα−1,4−グ
ルコシド結合を加水分解する酵素であり、各種生物中に
広く存在し、人体においては唾液由来のα−アミラーゼ
と膵臓由来のα−アミラーゼとが存在し、それぞれ口腔
内又は消化管内ででんぷんを糖に変換する役割を果たし
ている。α−アミラーゼインヒビターは、このα−アミ
ラーゼの活性を阻害するため、抗肥満のダイエット剤、
高血糖症の治療剤、糖尿病の治療薬、虫歯の予防薬など
として有用なものである。このため、これまでにα−ア
ミラーゼインヒビターを種々の原料物質から抽出して取
得することが試みられており、例えば小麦中に含まれる
α−アミラーゼインヒビターを抽出する方法が知られて
いる(特開昭57−140727号、特開昭60−41
32号公報等)。一方、リパーゼは脂肪を加水分解する
酵素であり、人体においては膵液に存在する。リパーゼ
インヒビターは、このリパーゼの活性を阻害するため、
抗肥満のダイエット剤、高脂血症の治療剤などとして有
用である。BACKGROUND OF THE INVENTION α-Amylase is an enzyme that hydrolyzes α-1,4-glucoside bonds such as starch and glycogen. It is widely present in various organisms and saliva in the human body. There are α-amylase derived from the pancreas and α-amylase derived from the pancreas, which play a role of converting starch into sugar in the oral cavity or the digestive tract, respectively. The α-amylase inhibitor inhibits the activity of this α-amylase, and therefore is an antiobesity diet drug,
It is useful as a therapeutic agent for hyperglycemia, a therapeutic agent for diabetes, a preventive agent for dental caries and the like. For this reason, it has been attempted to extract and obtain α-amylase inhibitors from various raw materials, and for example, a method for extracting α-amylase inhibitors contained in wheat is known (Japanese Patent Application Laid-Open No. 2004-242242). JP-A-57-140727, JP-A-60-41
No. 32, etc.). On the other hand, lipase is an enzyme that hydrolyzes fat and is present in pancreatic juice in the human body. Lipase inhibitors block the activity of this lipase,
It is useful as an anti-obesity diet agent, a therapeutic agent for hyperlipidemia and the like.
【0003】上記のように、小麦又は小麦粉中にはα−
アミラーゼインヒビターが含まれていることは知られて
いるが、このα−アミラーゼインヒビターを小麦又は小
麦粉から取り出すには、小麦又は小麦粉の水抽出液を加
熱処理し、有機溶媒で分画沈殿させ、沈殿部分を採取し
てその溶液を吸着剤処理し、塩溶液で溶出し、クロマト
グラフィーによって分画するという極めて複雑な操作に
よって所望のα−アミラーゼインヒビターを得るもので
あって、効果的かつ経済的な方法であるとは言えない。
また、このような方法で得られるα−アミラーゼインヒ
ビターは必然的に高価なものとなり、従って、α−アミ
ラーゼインヒビターを多量にかつ安価に提供することを
必要とするダイエット剤の用途には不適当であった。ま
た、従来得られているα−アミラーゼインヒビターが、
α−アミラーゼだけでなくリパーゼの活性を阻害する作
用をも有するかどうかについては、これまで全く報告さ
れていない。As mentioned above, α-in wheat or flour.
It is known that an amylase inhibitor is contained, but in order to remove this α-amylase inhibitor from wheat or flour, a water extract of wheat or flour is heat-treated, fractionated by an organic solvent, and precipitated. The desired α-amylase inhibitor is obtained by a very complicated operation of collecting a portion, treating the solution with an adsorbent, eluting with a salt solution, and fractionating by chromatography. Not a method.
Further, the α-amylase inhibitor obtained by such a method is inevitably expensive, and is therefore unsuitable for use as a dieting agent which requires providing a large amount of the α-amylase inhibitor at low cost. there were. In addition, the conventionally obtained α-amylase inhibitor is
Whether or not it has an effect of inhibiting the activity of not only α-amylase but also lipase has not been reported at all.
【0004】従って、本発明の目的は、α−アミラーゼ
だけでなくリパーゼ等の各種消化酵素の活性をも阻害す
る作用を有する消化酵素活性阻害物質を簡単にかつ安価
に提供し、もって抗肥満、及び高血糖、高脂血症等の抑
制に有用なダイエット食品を安価に提供することにあ
る。Therefore, an object of the present invention is to provide a digestive enzyme activity-inhibiting substance having an action of inhibiting not only the activity of α-amylase but also various digestive enzymes such as lipase easily and inexpensively. Another object of the present invention is to provide a diet food useful for suppressing hyperglycemia, hyperlipidemia and the like at low cost.
【0005】[0005]
【課題を解決するための手段】本発明によれば、前記目
的を達成するために、海藻の抽出液を濾過・精製して得
られる消化酵素活性阻害物質が提供される。さらにま
た、本発明によれば、該海藻の抽出液を濾過・精製して
得られる消化酵素活性阻害物質を含有するダイエット食
品が提供される。According to the present invention, in order to achieve the above object, a digestive enzyme activity inhibitory substance obtained by filtering and purifying an extract of seaweed is provided. Furthermore, according to the present invention, there is provided a diet food containing a digestive enzyme activity inhibitor obtained by filtering and purifying the extract of seaweed.
【0006】[0006]
【発明の作用及び態様】本発明者は、海藻からの抽出物
が高いα−アミラーゼ活性阻害作用を有するだけでな
く、リパーゼ活性阻害作用をも有し、しかも抽出操作に
よって簡単に得られることを見い出し、本発明を完成す
るに至ったものである。すなわち、本発明の消化酵素
(α−アミラーゼ、リパーゼ)活性阻害物質は、海藻の
抽出物からなる。本発明に供される海藻類としては、褐
藻類(ワカメ、コンブ、カジメ、アラメ、オオバモク、
モズク、ホンダワラ等)、緑藻類(アナアオサ、アオノ
リ、ミル等)、紅藻類(オゴノリ、ヒラクサ、フクロノ
リ等)などが挙げられる。なかんずく、褐藻類の活性が
極めて高い。The present inventor has found that the extract from seaweed has not only a high α-amylase activity inhibitory action but also a lipase activity inhibitory action and can be easily obtained by an extraction procedure. They have found the present invention and completed the present invention. That is, the digestive enzyme (α-amylase, lipase) activity-inhibiting substance of the present invention comprises a seaweed extract. The seaweeds used in the present invention include brown algae (seaweed, kelp, squid, sardine, psyllium,
Mozuku, Honda straw, etc.), green algae (Anaosa, Aonori, mill, etc.), red algae (Ogonori, Hirakusa, Fukuronori, etc.) and the like. Above all, the activity of brown algae is extremely high.
【0007】本発明の消化酵素(α−アミラーゼ、リパ
ーゼ)活性阻害物質は、上記のような藻類を適当に裁断
する等以外は未処理のまま適当な溶媒で抽出することに
よって得られる。抽出方法、温度等は特に限定されない
が、抽出効率の面から溶媒を海藻と共に熱時抽出させる
ことによって行うことが好ましい。還流温度は、使用す
る溶媒によって異なるが、100℃以上の温度を使用し
ても本発明のα−アミラーゼインヒビターの活性が損な
われることはない。The digestive enzyme (α-amylase, lipase) activity-inhibiting substance of the present invention can be obtained by extracting with a suitable solvent as it is untreated, except for appropriately cutting algae as described above. The extraction method, temperature, etc. are not particularly limited, but from the viewpoint of extraction efficiency, it is preferable to carry out the extraction by hot extraction of the solvent with seaweed. The reflux temperature varies depending on the solvent used, but the use of a temperature of 100 ° C. or higher does not impair the activity of the α-amylase inhibitor of the present invention.
【0008】なお、溶媒としては水、アルコール類、ア
セトンなど水に可溶な有機溶媒のほか、ベンゼン、トル
エンなどの芳香族炭化水素類や、クロロホルム、四塩化
炭素などの脂肪族炭化水素のハロゲン化化合物などが挙
げられる。また、エーテル、エステル、ケトンなども使
用できるが、低沸点のものが好ましい。また、抽出後の
使用における安全性及び便宜の観点からは水、アルコー
ル類が好ましい。エーテル系溶媒としては、エチルエー
テル、イソプロピルエーテル、ジメチルジオキサン、カ
ルビトール、セロソルブ類等が挙げられる。エステル系
溶媒としては、酢酸エチル、酢酸プロピル、酢酸ブチ
ル、プロピオン酸メチル、蟻酸アミル、蟻酸ブチル、乳
酸メチル、アクリル酸メチル、アクリル酸エチル等が挙
げられる。ケトン系溶媒としては、アセトン、ジエチル
ケトン、メチルエチルケトン、メチルブチルケトン、メ
チルプロピルケトン等が挙げられる。アルコール系溶媒
としては、メチルアルコール、エチルアルコール、プロ
ピルアルコール、ブチルアルコール、アミルアルコー
ル、アセトニルメタノール等が挙げられる。As the solvent, in addition to water-soluble organic solvents such as water, alcohols, and acetone, aromatic hydrocarbons such as benzene and toluene, and halogens of aliphatic hydrocarbons such as chloroform and carbon tetrachloride. Compound and the like. Further, ethers, esters, ketones and the like can be used, but those having a low boiling point are preferable. In addition, water and alcohols are preferable from the viewpoint of safety and convenience in use after extraction. Examples of ether solvents include ethyl ether, isopropyl ether, dimethyldioxane, carbitol, cellosolves and the like. Examples of the ester solvent include ethyl acetate, propyl acetate, butyl acetate, methyl propionate, amyl formate, butyl formate, methyl lactate, methyl acrylate, ethyl acrylate and the like. Examples of the ketone solvent include acetone, diethyl ketone, methyl ethyl ketone, methyl butyl ketone, methyl propyl ketone and the like. Examples of the alcohol solvent include methyl alcohol, ethyl alcohol, propyl alcohol, butyl alcohol, amyl alcohol, acetonylmethanol and the like.
【0009】以上のようにして得られた消化酵素(α−
アミラーゼ、リパーゼ)活性阻害物質を含有する水溶
液、又は抽出液を所望に応じて噴霧乾燥、凍結乾燥、減
圧乾燥等の公知の方法により乾燥して粉末状にした固体
物質は、そのままダイエット剤として用いたり、また適
当な食品担体に添加することができる他、液剤化、錠剤
化もしくは顆粒剤化のための公知の助剤と共に製剤化さ
れる。これらの製剤化のための助剤としては、公知の賦
形剤、増量剤、滑沢剤、結合剤、香料、着色料等の添加
剤を使用することができる。上記の消化酵素(α−アミ
ラーゼ、リパーゼ)活性阻害物質を含有する固体物質
は、上記助剤と共に公知の錠剤化手段又は顆粒化手段に
より錠剤又は顆粒剤とされる。The digestive enzyme (α-
An aqueous solution containing an amylase, lipase) activity-inhibiting substance or an extract, if desired, is dried by a known method such as spray drying, freeze drying, or vacuum drying to obtain a powdery solid substance, which is directly used as a dieting agent. Alternatively, it may be added to a suitable food carrier, or may be formulated with a known auxiliary agent for liquid formulation, tableting or granulation. Known additives such as excipients, fillers, lubricants, binders, fragrances, and colorants can be used as auxiliaries for formulation of these. The solid substance containing the above-mentioned digestive enzyme (α-amylase, lipase) activity inhibitor is made into tablets or granules by the known tableting means or granulating means together with the above-mentioned auxiliaries.
【0010】このようにして得られた消化酵素(α−ア
ミラーゼ、リパーゼ)活性阻害物質を含有するダイエッ
ト食品(本明細書中では上記錠剤、顆粒剤等を含む広い
概念を意味する)は、食物として摂取されたでんぷん質
や脂肪の分解を妨げ、エネルギー源として消化、吸収さ
れるのを防ぐ。そのため、肥満症や高血糖症、高脂血症
などを効果的に抑制することができる。The diet food containing the digestive enzyme (α-amylase, lipase) activity inhibitor thus obtained (in the present specification means a broad concept including the above-mentioned tablets, granules, etc.) is a food. It prevents the breakdown of starch and fat ingested as, and prevents it from being digested and absorbed as an energy source. Therefore, obesity, hyperglycemia, hyperlipidemia and the like can be effectively suppressed.
【0011】[0011]
【実施例】以下、実施例を示して本発明について具体的
に説明する。 実施例1 食用になる海藻の中から、表1に記載した緑藻類、褐藻
類、紅藻類それぞれの代表的な海藻を数種ずつ採取し
た。そして、それぞれ未処理の生の海藻100gを粉砕
し、それぞれを表1に示した溶媒100mLと共に30
分間加熱還流した後、抽出液を濾過し、その濾液を減圧
濃縮・乾固した残渣をエタノール50mLで溶解し、そ
のエタノール可溶部を濾別した濾液を再度減圧濃縮・乾
固して0.1%の水溶液にした抽出物を得た。EXAMPLES The present invention will be specifically described below with reference to examples. Example 1 From the edible seaweed, several representative seaweeds of each of the green algae, brown algae, and red algae listed in Table 1 were collected. Then, 100 g of untreated raw seaweed was crushed, and each was crushed together with 100 mL of the solvent shown in Table 1 to 30
After heating under reflux for a minute, the extract was filtered, the residue obtained by concentrating and drying the filtrate under reduced pressure was dissolved in 50 mL of ethanol, and the ethanol-soluble portion was filtered off. The extract was made into a 1% aqueous solution.
【0012】試験例1(各種海藻類からの抽出物のα−
アミラーゼ活性阻害作用) 上記実施例1で得られた抽出物質が、α−アミラーゼが
でんぷんを加水分解するのを阻害する度合いを測定し
た。試験は、以下のように、抽出物のα−アミラーゼ活
性阻害の有無について、水(ブランクテスト)と比較す
ることによって行った。まず、9本の試験管に水1mL
ずつを入れ、その最初のものに1mLのα−アミラーゼ
1%水溶液を加えてよく混合し、そのうちの1mLを取
って次の試験管に入れて混合し、その1mLをさらに次
の試験管に加えて混合する。この操作を順次繰り返し、
最後の1mLは捨てる。そうすれば、α−アミラーゼ1
%水溶液を0.5、0.25、0.12、0.06、→
0.0019mLを採り、水で全量1mLにした液が9
本得られる。水を入れず、α−アミラーゼ1%水溶液の
みを採ったものを1本付ける。以上、10本の試験管の
組を検体の数とブランクテスト分を用意し、氷水中に冷
却しておく。次いで、各試験管に上記実施例1で得られ
たそれぞれの海藻抽出物の0.1%水溶液0.2mLず
つを入れ、一方、ブランクテストとしては水を各試験管
に0.2mLずつ入れ、さらに、各試験管に可溶性でん
ぷん5mLずつを加え、全部加え終った後一度に40℃
の恒温槽に入れて30分間放置する。Test Example 1 (α-of extracts from various seaweeds)
Amylase activity inhibitory action) The degree to which the extract material obtained in Example 1 above inhibits α-amylase from hydrolyzing starch was measured. The test was carried out by comparing the presence or absence of α-amylase activity inhibition of the extract with water (blank test) as follows. First, 1 mL of water in 9 test tubes
Add 1 mL of 1% α-amylase aqueous solution to the first one and mix well, take 1 mL of it and mix in the next test tube, add 1 mL to the next test tube And mix. Repeat this operation in sequence,
Discard the last 1 mL. Then α-amylase 1
% Aqueous solution 0.5, 0.25, 0.12, 0.06, →
0.0019mL was taken and the total volume was 1mL with water.
The book is obtained. Attach one of the 1% aqueous solution of α-amylase without water. As described above, a set of 10 test tubes is prepared for the number of samples and a blank test and cooled in ice water. Then, 0.2 mL of each 0.1% aqueous solution of the seaweed extract obtained in Example 1 was placed in each test tube, while 0.2 mL of water was placed in each test tube as a blank test. Furthermore, add 5 mL of soluble starch to each test tube, and after adding all, add 40 ° C at a time.
Put it in the constant temperature bath and leave it for 30 minutes.
【0013】一定時間後、再び氷水中に入れて冷却す
る。そして、各試験管の上端より指の幅ぐらいのところ
まで水を加え、0.1Nヨード液1滴ずつを加える。す
ると、各試験管は青紫、紫、赤、黄などの色を呈する
が、このうち青色が認められなくなり、紫色を呈する試
験管を取り、この試験管中に存するα−アミラーゼの量
から1mLのα−アミラーゼ液により分解される1%で
んぷん液のmL数を算出する。例えば、0.02mLの
α−アミラーゼ液を入れたものが30分で紫色を呈し、
それよりα−アミラーゼ量の少ないものは青色であった
とすれば、0.02mLのα−アミラーゼ液が1%でん
ぷん液5mL青色ヨード反応のなくなるまで分解したこ
とになる。したがって、1mLのα−アミラーゼ液が分
解すべき1%でんぷん液の量は250mLである。よっ
て、α−アミラーゼのでんぷん糊精化力は、下記数1の
如く表される。After a certain period of time, it is again put in ice water and cooled. Then, water is added from the upper end of each test tube up to about the width of the finger, and one drop of 0.1N iodine solution is added. Then, each test tube exhibits a color such as blue-violet, purple, red, and yellow, but among these, blue color is no longer observed, and a test tube exhibiting a purple color is taken, and 1 mL of the amount of α-amylase present in the test tube Calculate the number of mL of 1% starch solution decomposed by the α-amylase solution. For example, the one containing 0.02 mL of α-amylase solution turns purple in 30 minutes,
If the one with a smaller amount of α-amylase was blue, it means that 0.02 mL of the α-amylase solution was decomposed until the 1% starch solution 5 mL of the blue iodine reaction disappeared. Therefore, the amount of 1% starch liquid that 1 mL of α-amylase solution should decompose is 250 mL. Therefore, the starch-refining power of α-amylase is represented by the following formula 1.
【数1】 したがって、このでんぷん糊精化力の変化を調べれば、
α−アミラーゼの活性阻害の有無がわかる。[Equation 1] Therefore, if you examine the changes in the starch paste refining ability,
The presence or absence of inhibition of α-amylase activity is known.
【0014】上記のようにして得られた、海藻からの抽
出物質によるでんぷん糊精化力の阻害の度合いの試験結
果を次の表1に示す。The following Table 1 shows the test results of the degree of inhibition of the starch paste refining ability of the seaweed extract obtained as described above.
【表1】 表1から明らかなように、本発明の海藻からの抽出物
は、高いでんぷん糊精化力阻害率を有し、α−アミラー
ゼ活性阻害作用に優れている。[Table 1] As is clear from Table 1, the extract from seaweed of the present invention has a high starch paste refining activity inhibition rate and an excellent α-amylase activity inhibitory action.
【0015】試験例2(各種海藻類からの抽出物のリパ
ーゼ活性阻害作用) 上記実施例1で得られた抽出物質が、脂肪を加水分解す
る酵素であるリパーゼの活性を阻害するかどうかを調べ
た。試験は、市販のリパーゼ測定用試薬「BMY」(ベ
ーリンガー・マンハイム社製)を用いて行った。これ
は、トリオレインを基質として用い、この懸濁液の濁度
の減少速度を紫外部で測定し、リパーゼ活性を求める方
法である。 また、キットの構成は下記表2の通りである。Test Example 2 (Lipase activity inhibitory action of extracts from various seaweeds) It was investigated whether the extract substance obtained in the above Example 1 inhibits the activity of lipase which is an enzyme that hydrolyzes fat. It was The test was carried out using a commercially available reagent for measuring lipase “BMY” (manufactured by Boehringer Mannheim). This is a method in which triolein is used as a substrate and the rate of decrease in the turbidity of this suspension is measured in the ultraviolet to determine the lipase activity. The composition of the kit is shown in Table 2 below.
【表2】 [Table 2]
【0016】試験は、実施例1で得られた海藻抽出物の
0.1%水溶液を用い、そのリパーゼ活性阻害の有無に
ついて、水(ブランクテスト)と比較することによって
行った。まず、緩衝/基質剤1ビンに精製水を総量で2
7.5mLになるように加え、内容物を溶解して試液を
作り、リパーゼは1mLの精製水で溶解してリパーゼ水
溶液を作る。試液をあらかじめ37℃に加温した後、キ
ュベットに2.5mL取り、そこに検体である海藻抽出
物の0.1%水溶液(ブランクテストは水)を0.1m
L加え、さらにリパーゼ水溶液0.1mLを入れて泡立
てないように混和し、37℃の恒温槽にて4分間インキ
ュベートした後、吸光度を読み、さらに5分間同様に3
7℃の恒温槽にてインキュベートした後(試料混和後9
分後)、吸光度を読む。その吸光度の変化量の差によっ
て、リパーゼの活性阻害の有無がわかる。すなわち、吸
光度の変化量がブランクテストに比べて小さければ、リ
パーゼの活性が阻害されているということになる。The test was carried out by using the 0.1% aqueous solution of the seaweed extract obtained in Example 1 and comparing the presence or absence of inhibition of lipase activity with water (blank test). First, the total amount of purified water in 1 bottle of buffer / substrate agent is 2
Add to 7.5 mL, dissolve the contents to make a test solution, and dissolve lipase in 1 mL of purified water to make a lipase aqueous solution. After preliminarily heating the test solution to 37 ° C., 2.5 mL was placed in a cuvette, and a 0.1% aqueous solution of seaweed extract (blank test was water) was added to the sample in a volume of 0.1 m.
L, 0.1 mL of an aqueous lipase solution was added, and the mixture was mixed without foaming, and the mixture was incubated in a constant temperature bath at 37 ° C. for 4 minutes, and then the absorbance was read.
After incubating in a constant temperature bath at 7 ° C (9 after mixing the sample
After a minute), read the absorbance. The presence or absence of inhibition of lipase activity can be determined from the difference in the amount of change in the absorbance. That is, if the amount of change in the absorbance is smaller than that in the blank test, it means that the activity of lipase is inhibited.
【0017】上記試験例2における海藻からの抽出物質
によるリパーゼ活性阻害の試験結果を次の表3に示す。The test results of inhibition of lipase activity by the extract from seaweed in Test Example 2 are shown in Table 3 below.
【表3】 表3から明らかなように、本発明の海藻からの抽出物は
リパーゼ活性阻害作用をも有する。[Table 3] As is clear from Table 3, the extract from seaweed of the present invention also has a lipase activity inhibitory action.
【0018】[0018]
【発明の効果】以上のように、本発明の海藻からの抽出
物は高いα−アミラーゼ活性阻害作用を有するだけでな
く、リパーゼ活性阻害作用をも有し、しかも抽出操作に
よって簡単に得られる。したがって、この消化酵素(α
−アミラーゼ、リパーゼ)活性阻害物質を含有するダイ
エット食品を安価に提供することができ、また、得られ
るダイエット食品は、食物として摂取されたでんぷん質
や脂肪の分解を妨げ、エネルギー源として消化、吸収さ
れるのを効果的に防ぎ、それによって、肥満症や高血糖
症、高脂血症などを効果的に抑制することができる。INDUSTRIAL APPLICABILITY As described above, the extract of seaweed of the present invention has not only a high α-amylase activity inhibitory action but also a lipase activity inhibitory action, and can be easily obtained by an extracting operation. Therefore, this digestive enzyme (α
-Amylase, lipase) It is possible to provide a diet food containing an activity inhibitor at a low cost, and the obtained diet food prevents the decomposition of starch and fat ingested as food and digests and absorbs it as an energy source. Can be effectively prevented, and thereby obesity, hyperglycemia, hyperlipidemia and the like can be effectively suppressed.
Claims (3)
消化酵素活性阻害物質。1. A digestive enzyme activity inhibitor obtained by filtering and purifying an extract of seaweed.
ることを特徴とする請求項1記載の消化酵素活性阻害物
質。2. The digestive enzyme activity inhibitor according to claim 1, wherein the seaweed is brown algae, green algae or red algae.
消化酵素活性阻害物質を含有するダイエット食品。3. A diet food containing a digestive enzyme activity inhibitor obtained by filtering and purifying an extract of seaweed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4116707A JPH05284937A (en) | 1992-04-10 | 1992-04-10 | Digestive enzyme activity-inhibiting substance extracted from sea alga and dietary food containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4116707A JPH05284937A (en) | 1992-04-10 | 1992-04-10 | Digestive enzyme activity-inhibiting substance extracted from sea alga and dietary food containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05284937A true JPH05284937A (en) | 1993-11-02 |
Family
ID=14693838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4116707A Pending JPH05284937A (en) | 1992-04-10 | 1992-04-10 | Digestive enzyme activity-inhibiting substance extracted from sea alga and dietary food containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH05284937A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005075744A (en) * | 2003-08-29 | 2005-03-24 | Toyama Prefecture | Antidiabetic agent and manufacturing method therefor |
WO2005056034A1 (en) * | 2003-12-10 | 2005-06-23 | Riken Vitamin Co., Ltd. | Alga extract and lipase inhibitor containing the same |
WO2005056035A1 (en) * | 2003-12-10 | 2005-06-23 | Riken Vitamin Co., Ltd. | Alga extract and sugar hydrolase inhibitor containing the same |
JP2006328010A (en) * | 2005-05-27 | 2006-12-07 | Chemo Sero Therapeut Res Inst | Lipid metabolism-improving substance containing phlorotannin |
JP2008500958A (en) * | 2003-11-11 | 2008-01-17 | ザ スキニー ドリンク カンパニー | Composition for prevention and treatment of obesity, cardiovascular disease and coronary artery disease |
WO2008096203A3 (en) * | 2006-10-18 | 2008-11-20 | Dermena | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders |
JP2012001524A (en) * | 2010-06-21 | 2012-01-05 | Kyoto Univ | Preadipocyte differentiation inhibitor |
KR20170006177A (en) | 2015-07-07 | 2017-01-17 | 고결 | Diet food manufacturing methods using natural mixture |
CN117547025A (en) * | 2024-01-12 | 2024-02-13 | 北京新浠芮生物技术有限公司 | Composition for controlling weight as well as preparation method and application thereof |
-
1992
- 1992-04-10 JP JP4116707A patent/JPH05284937A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005075744A (en) * | 2003-08-29 | 2005-03-24 | Toyama Prefecture | Antidiabetic agent and manufacturing method therefor |
JP2008500958A (en) * | 2003-11-11 | 2008-01-17 | ザ スキニー ドリンク カンパニー | Composition for prevention and treatment of obesity, cardiovascular disease and coronary artery disease |
WO2005056034A1 (en) * | 2003-12-10 | 2005-06-23 | Riken Vitamin Co., Ltd. | Alga extract and lipase inhibitor containing the same |
WO2005056035A1 (en) * | 2003-12-10 | 2005-06-23 | Riken Vitamin Co., Ltd. | Alga extract and sugar hydrolase inhibitor containing the same |
JP2006328010A (en) * | 2005-05-27 | 2006-12-07 | Chemo Sero Therapeut Res Inst | Lipid metabolism-improving substance containing phlorotannin |
WO2008096203A3 (en) * | 2006-10-18 | 2008-11-20 | Dermena | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders |
JP2012001524A (en) * | 2010-06-21 | 2012-01-05 | Kyoto Univ | Preadipocyte differentiation inhibitor |
KR20170006177A (en) | 2015-07-07 | 2017-01-17 | 고결 | Diet food manufacturing methods using natural mixture |
CN117547025A (en) * | 2024-01-12 | 2024-02-13 | 北京新浠芮生物技术有限公司 | Composition for controlling weight as well as preparation method and application thereof |
CN117547025B (en) * | 2024-01-12 | 2024-04-26 | 北京新浠芮生物技术有限公司 | Composition for controlling weight as well as preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0987027B1 (en) | Ethyl acetate extract from Indigo plant | |
EP1074262B1 (en) | Laminaria algae extract, method of preparation and cosmetic or pharmaceutical compositions containing the same | |
Gautam et al. | Healing effects of Aegle marmelos (L.) Correa fruit extract on experimental colitis | |
JPH05284937A (en) | Digestive enzyme activity-inhibiting substance extracted from sea alga and dietary food containing the same | |
JP3547782B2 (en) | Anti-Helicobacter pylori activator | |
JP2011201788A (en) | Anti-inflammatory agent | |
Khan et al. | In vitro antioxidant, anticholinesterase inhibitory, and antimicrobial activity studies of Terminalia chebula (Retz) and Terminalia arjuna (Roxb) | |
Prakash et al. | Studies on analysis of antioxidant and enzyme inhibitory activity of Vitex negundo Linn | |
CN102532345A (en) | O-unsaturated fatty acid acylated chitosan oligosaccharides as well as preparation and application thereof | |
JP2009013106A (en) | Xanthone derivative having inhibitory action on inflammatory cytokine production, method for producing the same and food preparation, cosmetic and anti-inflammatory agent comprising the same | |
JP5101769B2 (en) | Antibiotic antioxidant or preventive agent | |
JP2009280514A (en) | Organic acid peptide-bonded luteolin derivative exhibiting anti-oxidizing action and method for producing the same | |
JP2006241039A (en) | Urease inhibitor | |
JP2002284632A (en) | Extinction substance for superoxide anion extracted from sake lees as effective component | |
JPH11323326A (en) | Active oxygen eliminating agent, skin protecting agent and discoloration inhibitor | |
TWI525100B (en) | Trehalose azelaic acid ester, preparation method for the same and uses thereof | |
JPH10287582A (en) | Suppressant for liberation of histamine comprising bark extract | |
WO2019235866A1 (en) | Method for preparing fermented pineapple having increased antioxidant effect by using vitamin c | |
JP2004115536A (en) | Anti-helicobacter pylori activator | |
JPH078185A (en) | Propolis product and production thereof | |
JP2006016340A (en) | Blood uric acid level reduction agent having extract of punica granatum l. as active ingredient | |
Sunday et al. | Antioxidant property and phenolic content of Anthocleista vogelii root ethanolic extract and fractions | |
JP3113009B2 (en) | Whitening cosmetics | |
JPH0717873A (en) | Enzyme inhibitor | |
JP3150835B2 (en) | Process for producing lignan glycosides and lignans |